checkAd
    Startseite > Aktien > Tarsus Pharmaceuticals > Nachrichten
    Tarsus Pharmaceuticals Aktie
    32,42
     
    USD
    +0,68 %
    +0,22 USD
    Letzter Kurs 22:00:00 Nasdaq
    32,33
     
    USD
    400 STK
    Geldkurs 22:02:00
    32,45
     
    USD
    400 STK
    Briefkurs 22:02:00
    ISIN: US87650L1035 · WKN: A2QD8U · SYM: TARS · USA

    Neueste Nachrichten

    Tarsus to Participate in Upcoming Investor Conferences
    29.05.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
    09.05.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
    08.05.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
    01.05.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
    23.04.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus to Participate at Upcoming Investor Conferences
    05.03.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Introduces “Mite Party” Campaign for XDEMVY (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
    05.03.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Announces Pricing of $100.0 Million Public Offering
    01.03.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Announces Proposed $100.0 Million Public Offering
    29.02.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
    27.02.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease
    22.02.24 · globenewswire · Tarsus Pharmaceuticals
    Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024
    20.02.24 · globenewswire · Tarsus Pharmaceuticals